Infectious Diseases | Men's Health | Women's Health
What is the purpose of this trial?
This non-randomized, open-label study will address the following research aims in People who inject drugs (PWID):
- To assess the feasibility and acceptability of the Expanding PrEP Implementation in Communities of PWID (EPIC-P) intervention among high-risk PWID.
- To determine the preliminary efficacy of the EPIC-P intervention in terms of increasing adherence to PrEP and primary HIV prevention among high-risk PWID.
- Ages18 years and older
- Trial withYale University School of Medicine
- Start Date01/06/2020
- End Date03/15/2023
- Last Updated11/11/2022
- Study HIC#2000026228